However, this genetic profile was also associated with increased risks of neutropenia, infections, atopic conditions, and female infertility, likely due to elevated IL-4 levels—emphasizing the need for careful evaluation of IL-6 receptor blockade as a vascular risk reduction strategy [122]. This evidence concerns the gene IL4 and neutropenia.